These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2559361)

  • 1. Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice.
    Semba J; Kuroda Y; Takahashi R
    Neuropsychobiology; 1989; 21(3):152-6. PubMed ID: 2559361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of the GABA transaminase inhibitors gamma-vinylGABA and aminooxyacetic acid on arterial pressure following injection into nucleus tractus solitarius.
    Tsukamoto K; Sved AF
    Neuropharmacology; 1993 Jun; 32(6):575-9. PubMed ID: 8336820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus.
    Qume M; Fowler LJ
    Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anticonvulsant effects of GABA-T inhibitors and glycine.
    Seiler N; Sarhan S
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):49-57. PubMed ID: 6472485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons.
    Gram L; Larsson OM; Johnsen AH; Schousboe A
    Epilepsy Res; 1988; 2(2):87-95. PubMed ID: 3143560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression by sodium valproate of gamma-vinyl GABA-induced facilitation of visual evoked potentials in rats.
    Myslobodsky MS; Morag M
    Electroencephalogr Clin Neurophysiol; 1981 Nov; 52(5):445-50. PubMed ID: 6171410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
    Gale K; Iadarola MJ
    Science; 1980 Apr; 208(4441):288-91. PubMed ID: 6768130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]gamma-vinyl-GABA to GABA-transaminase in brain homogenates.
    Gale K
    Life Sci; 1984 Feb; 34(7):701-6. PubMed ID: 6700374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity.
    Iadarola MJ; Gale K
    Mol Cell Biochem; 1981 Sep; 39():305-29. PubMed ID: 6273710
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
    Neal MJ; Shah MA
    Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic regulation of striatal opioid gene expression.
    Reimer S; Höllt V
    Brain Res Mol Brain Res; 1991 Apr; 10(1):49-54. PubMed ID: 1647482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus.
    Qume M; Whitton PS; Fowler LJ
    J Neurochem; 1995 May; 64(5):2256-61. PubMed ID: 7722510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the pharmacology of inhibitors of GABA-metabolism.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):119-28. PubMed ID: 6782493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.